Qu Yuan, Shi Lin, Liu Yu, Huang Lv, Luo Huai-Rong, Wu Gui-Sheng
Key Laboratory for Aging and Regenerative Medicine, Department of Pharmacology School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.
Department of Pharmacy Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400000, China.
Oxid Med Cell Longev. 2022 Feb 21;2022:8878923. doi: 10.1155/2022/8878923. eCollection 2022.
Age is the major risk factor for most of the deadliest diseases. Developing small molecule drugs with antiaging effects could improve the health of aged people and retard the onset and progress of aging-associated disorders. Bioactive secondary metabolites from medicinal plants are the main source for development of medication. Orientin is a water-soluble flavonoid monomer compound widely found in many medicinal plants. Orientin inhibits fat production, antioxidation, and anti-inflammatory activities. In this study, we explored whether orientin could affect the aging of . We found that orientin improved heat, oxidative, and pathogenic stress resistances through activating stress responses, including HSF-1-mediated heat shock response, SKN-1-mediated xenobiotic and oxidation response, mitochondria unfolded responses, endoplasmic unfolded protein response, and increased autophagy activity. Orientin also could activate key regulators of the nutrient sensing pathway, including AMPK and insulin downstream transcription factor FOXO/DAF-16 to further improve the cellular health status. The above effects of orientin reduced the accumulation of toxic proteins (-synuclein, -amyloid, and poly-Q) and delayed the onset of neurodegenerative disorders in AD, PD, and HD models of and finally increased the longevity and health span of . Our results suggest that orientin has promising antiaging effects and could be a potential natural source for developing novel therapeutic drugs for aging and its related diseases.
年龄是大多数致命疾病的主要风险因素。开发具有抗衰老作用的小分子药物可以改善老年人的健康状况,并延缓与衰老相关疾病的发生和发展。药用植物中的生物活性次生代谢产物是药物开发的主要来源。荭草素是一种水溶性黄酮类单体化合物,广泛存在于许多药用植物中。荭草素具有抑制脂肪生成、抗氧化和抗炎活性。在本研究中,我们探讨了荭草素是否会影响[具体对象未明确]的衰老。我们发现,荭草素通过激活应激反应来提高热应激、氧化应激和病原体应激抗性,这些应激反应包括HSF-1介导的热休克反应、SKN-1介导的外源物质和氧化反应、线粒体未折叠反应、内质网未折叠蛋白反应,并增加自噬活性。荭草素还可以激活营养感应途径的关键调节因子,包括AMPK和胰岛素下游转录因子FOXO/DAF-16,以进一步改善细胞健康状态。荭草素的上述作用减少了有毒蛋白质(α-突触核蛋白、β-淀粉样蛋白和多聚谷氨酰胺)的积累,并延缓了阿尔茨海默病、帕金森病和亨廷顿舞蹈病模型中神经退行性疾病的发生,并最终延长了[具体对象未明确]的寿命和健康期。我们的结果表明,荭草素具有显著的抗衰老作用,可能是开发治疗衰老及其相关疾病新型治疗药物的潜在天然来源。